Niosome encapsulated bleomycin

S.T.P. Pharma Sciences

Volumn 6, Issue 1, 1996, Pages 61-71

  Raja Naresh, R A ^a   Udupa, N ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Antitumour activity; Bleomycin; Niosome

Indexed keywords

BLEOMYCIN; NIOSOME; SURFACTANT;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; MOUSE; NONHUMAN; PARTICLE SIZE;

EID: 0029937625     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. JULIANO R.L. - Microparticulate drug carriers. - In : Controlled Drug Delivery : Fundamentals and Applications, R.L. Juliano and V.H.L. Lee Eds., Marcel Dekker, New York and Basel, 1987, pp. 556-580.
2. VITETTA E.S., KROLICK K.A., MIYAMA-IANAB M., CUSHLEY W. and UHR J.W. - Immunotoxins : a new approach to cancer therapy. - Science, 219, 644-650, 1983.
3. POZNANSKY M.J. and CLEVELAND L.G. - Biological macromolecules as carriers of drugs and enzymes. - In : Drug Delivery Systems, R.L. Juliano Ed., Oxford University Press, New York, 1980, pp. 253-315.
4. JULIANO R.L. and LAYTON D. - Liposomes as a drug delivery system. - In : Drug Delivery Systems, R.L. Juliano Ed., Oxford University Press, New York, 1980, pp. 189-236.
5. WIDDER K.J. and SENYEI A.E. - Magnetic microspheres : a vehicle for selective targeting of drugs. - Pharm. Ther., 20, 151-170, 1983.
6. LANGER R. - Implantable controlled release systems. - Pharm. Ther., 21, 35-52, 1983.
7. IHLER G.M. - Erythrocyte carriers. - Pharm. Ther., 20, 151-170, 1983.
8. BAILLIE A.J., FLORENCE A.T., HUME L.R., MUIRHEAD G.T. and ROGERSON A. - The preparation and properties of niosomes-non-ionic surfactant vesicles. - J. Pharm. Pharmacol., 38, 863-868, 1985.
9. AZMIN M.N., FLORENCE A.T., HANDJANI VILA R M., STEWART J.F., VANLERBERGHE G. and WHITTAKER J.S. -The effect of non-ionic surfactant vesicle (niosome) entrapment of the absorption and distribution of methotrexate in mice. - J. Pharm. Pharmacol., 37, 237-242, 1985.
10. PIDGEON C., McNEELY S., SCHMIDT T. and JOHNSON J.E. - Multilayered vesicles prepared by reverse-phase evaporation : liposome structure and optimum solute entrapment. -Biochemistry, 26, 17-29, 1987.
11. VAN BEUNINGEN D., STREFFER C. and BENTHOLDT G. - Mikronukleusbilding in Vergleich zur Uberlebensrate und menschlichen Melanom-Zellen nach Rontgen, Neutroneubestrahlung und Hypertherie. - Strahlentherapie, 157, 600-606, 1981.
12. UMA DEVI P. and SHARMA A.S.K.V.S. - Mouse bone marrow response to low doses of whole-body gamma radiation : induction of micronuclei. - Int. J. Radiat. Biol., 57, 97-100, 1990.
13. GREGORIADIS G. and FLORENCE A.T. - Liposomes in drug delivery, clinical, diagnostic and ophthalmic potential - Drugs, 45, 15-28, 1993.
14. GREGORIADIS G. and FLORENCE A.T. - Liposomes and cancer therapy. - Cancer Cells, 3, 144-146, 1991.
15. ROGERSON A., CUMMINGS J., WILLMOTT N. and FLORENCE A.T. - The distribution of doxorubicin in mice following administration in mosomes. - J. Pharm. Pharmacol., 40, 337-342, 1988
16. HUNTER C.A., DOLAN T.F., COOMBS G.H. and BAILLIE A.J. - Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. - J. Pharm. Pharmacol., 40, 161-165, 1988.
17. KERR D.J., ROGERSON A., MORRISON G.J., FLORENCE A.T. and KAYE S.B. - Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and Xenograft. - Br. J. Cancer, 58, 432-436, 1986.
18. OSTRO M.J. - Industrial application of liposomes : what does that mean? - In : Liposomes as Drug Carriers, G. Gregonadis Ed , John Wiley and Sons, New York, 1988, pp. 855-862.
19. TERASIMA T. and UMEZAWA H. - Lethal effects of bleomycin on cultured mammalian cells. - J. Antibiot., 23, 300-304, 1970.
20. BARRANCO S C. and HUMPHREY R M. - The effects of bleomycin on survival and cell progression in Chinese hamster cells in vitro. - Cancer Res., 31, 1218-1223, 1971.
21. RAHMAN A., WHITE G., MORE N. and SCHEIN P.S. -Pharmacological, toxicological and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes. - Cancer Res., 45, 796-803, 1985.
22. HEDDLE J A. and CARRANO A.V. - The DNA content of micronuclei induced in bone marrow by gamma radiation : evidence that micronuclei arise from acentric chromosomal fragments. - Mutat. Res., 44, 63-69, 1977.
23. JENSEN D. and RAMEL C. - Dose response at low doses of X-irradiation and MMS on the induction of micronuclei in mouse erythroblasts. - Mutat. Res , 41, 311-315, 1976.
24. AGAMOHAMMADI S.Z , HENDERSON I.L. and COLE R.J. -The human lymphocyte micronucleus assay : response of cord blood lymphocytes to irradiation and bleomycin. - Mutat. Res., 130, 395-398, 1984.
25. UMEZAWA H., ISHIZUKA M., MAEDA K. and TAKEUCHI I. -Studies on bleomycin. - Cancer, 20, 891-895, 1967.
26. UMEZAWA H., ISHIZUKA M., HORI S , CHIMURA H., TAKEUCHIA T. and KOMAIP. - The distribution of 3H bleomycin in mouse tissue. - J. Antibiot., 21, 638-642, 1968.
27. KUNIMOTO T., HORI M. and UMEZAWA W. - Modes of action of pleomycin, bleomycin and formycin in HeLa-S3 cells in synchronized culture. - J. Antibiot., 20, 227-281, 1967.
28. MOORE L.W. and LITTLE J.B. - Rapid and slow rejoining in non-dividing human diploid fibroblasts treated with bleomycin and ionizing radiation - Cancer Res., 45, 1982-1986, 1985.
29. CHAKRABARTHI A. and CHAKRABARTHI S. - High yield of micronuclei and micronuclei premature chromosome condensation in a mouse tumour cell like cultured in vivo with prearrested mitotic metaphases. - Neoplasma, 34, 557-562, 1987.
30. TERASIMA T., YAKUKAWA M. and UMEZAWA H. - Breaks and rejoining of DNA in cultured mammalian cells treated with bleomycin. - Gann., 61, 513-516, 1970.
31. SAITO M. and ANDOH T. - Breakage of a DNA protein complex induced by bleomycin and their repair in cultured mouse fibroblasts. - Cancer Res., 33, 1969-1970, 1973.
32. KOBAYASHI T., KATOAKA T., TSUKAGOSHI S. and SAKURAI Y. - Enhancement of antitumour activity of 1-beta-D-arabinofuranosylcytosine by encapsulation in liposomes. - Int. J Cancer, 20, 581-587, 1977.
33. MAYHEW E., PAPAHADJOPOULOS D., RUSTUM Y.M. and DAVE C. - Use of liposomes for the enhancement of cytotoxic effects of cytosine arabinoside. - Ann. NY Acad. Sci, 308, 371-386, 1978.
34. HWANG K.J. - Liposome pharmacokinetics. - In : Liposomes from Biophysics to Therapeutics, M.J. Ostro Ed., Marcel Dekker, New York, 1987, pp 109-156.
35. PROFFIT R., WILLIAMS C., PRESANT C., TIN G., ULIANA J., GAMBLE R and BALDESCHWIELER J. - Tumour imaging potential of liposomes loaded with ln-111-NTA biodistribution in mice. - J. Nucl Med., 24, 45-55, 1983.
36. GABIZON A., DAGAN A., GOREN D., BARENHOLZ Y. and FUKS Z. - Liposomes as in vivo carriers of adriamycin : reduced cardiac uptake and preserved antitumour activity in mice. -Cancer Res., 42, 4734-4739, 1982.
37. SUR P., HAZRA B. and ROY D.K. - Enhancement of the activity of bleomycin on Ehrlich ascites carcinoma cells by liposomal encapsulation. - Indian J. Exp. Biol., 22, 115-119, 1984.
38. FINKELSTEIN M.C., KUHN S.H., SCHIEREN H., WEISSMANN G. and HOFFSTEIN S. - Liposome uptake by human leukocytes. Enhancement of entry mediated by human serum and aggregated immunoglobulins. - Biochem. Biophys. Acta, 673, 286-302, 1981.
39. HSU M.J. and JULIANO R.L. - Interactions of liposomes with the reticuloendothelial system. II. Non-specific and receptor mediated uptake of liposomes by mouse peritoneal macrophages. - Biochem. Biophys. Acta, 720, 411-419, 1982.